FDA makes app first mobile contraceptive
The condom, the pill and now, the smartphone?
Natural Cycles, a mobile fertility app, this month became the first-ever digital contraceptive device to win FDA marketing approval. Women take their temperatures and track their menstrual cycle on the app, which uses an algorithm to determine when they’re fertile and should abstain from unprotected sex or use protection. In effect, it’s a form of the rhythm or calendar method.
The Swedish startup says it’s effective and lets women
avoid side effects common with other methods like birth
control pills. But reports of unwanted pregnancies and investigations by authorities in two countries in Europe, where it received EU certification in 2017, have raised questions about marketing what is essentially a health monitor as a contraceptive.
Natural Cycles boasts more than 900,000 users, and such fast growth underscores risks for regulators and concerns among health professionals as they grapple with the rapidly emerging market for mobile and digital health applications.
“Apps are incredibly popular and there’s nothing inherently wrong about using tech to support our health,” said Bekki Burbidge, deputy chief executive of the Family Plan- ning Association, a British sexual health organization. “But they’re also an area that is fairly unregulated and it can be hard to sort the good, evidence- and research-based apps from the bad.”
The app is similar to hundreds of other period track- ers already available, most of which are aimed at help- ing women conceive. But FDA approval means it can be marketed as a mobile contraceptive, giving it an edge in the mobile medical apps market, which is fore- cast to grow to $11.2 billion by 2025, up from at $1.4 billion in 2016, according to BIS Research. The makers of Natural Cycles acknowledge it’s not 100 percent effective and some women might still get pregnant even if used perfectly. The Food and Drug Admin- istration regulates apps and gadgets that collect or track medical information as medical devices, though it doesn’t scrutinize many more that merely perform simple tasks
like tracking calories. Marketing of contraceptive apps needs to be extremely careful to ensure that women
understand exactly what they’re signing up for and the limitations, the Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynecologists said in a statement.
The birth control pill’s failure rate is 9 percent, while for condoms it’s 18 percent and 24 percent for fertility-awareness methods, but those figures are backed up by much more long-term data.
The company’s founders, Elina Berglund and Raoul Scherwitzl, are a married couple who are both former physicists. Berglund was part of a team of scientists looking for the Higgs boson par
ticle at the European Organization for Nuclear Research, or CERN, in Switzerland. They pivoted from science to startups when they wrote the algorithm to help them have a baby and then developed an app to tap broader demand.